» Articles » PMID: 39431297

Carotid Artery Stenting for Symptomatic Carotid Near Occlusions: Feasibility, Safety and Outcome Analysis

Abstract

Introduction: Extracranial internal carotid stenosis (EICS) is a well-established cause of stroke. Carotid near-occlusion (CNO), either distally collapsed or not, is a rare sub-type of EICS with conflicting data regarding the necessity for treatment. The aim of this study is to evaluate the results of carotid artery stenting (CAS) for patients with symptomatic CNOs.

Material And Methods: Institutional review board (I06-420-23) approval was obtained for this retrospective study. Consecutive data from January 2019 to January 2023 was obtained. Sixty-five patients underwent 66 procedures for symptomatic CNOs. Diagnosis of CNOs were made with DSA images. Treatment decisions were made by a multidisciplinary team. Patient data including age, gender, clinical presentation, affected side, complications (initial/ follow-up), and pre and post mRS scores were recorded and analyzed.

Results: There were 22 female and 43 male patients with symptomatic CNOs (mean age: 71.52 ± 9.32 years). The mean time from symptom-to-treatment was 3.91 weeks ± 3.74 weeks (ranging from 0 to 20 weeks). There were eight events recorded in the 30 days period after CAS; five (7.7%) were cerebral hyperperfusion syndrome (one causing haemorrhage) and three (4.5%) ischemic complications. Permanent neurologic deficit rate was 6% and 61 patients (94%) mRS scores were unchanged during last follow-up. Mean follow-up period was 22.94 ± 16.67 months (ranging from 0.5 to 60 months).

Conclusion: Our study demonstrated that in the complex population of patients with symptomatic CNOs, CAS is a feasible option with acceptable rate of permanent neurologic deficits. Further studies are needed to assess its safety and long-term efficacy.

References
1.
Kokkinidis D, Chaitidis N, Giannopoulos S, Texakalidis P, Haider M, Aronow H . Presence of Contralateral Carotid Occlusion Is Associated With Increased Periprocedural Stroke Risk Following CEA but Not CAS: A Meta-analysis and Meta-regression Analysis of 43 Studies and 96,658 Patients. J Endovasc Ther. 2020; 27(2):334-344. DOI: 10.1177/1526602820904163. View

2.
Bonati L, Kakkos S, Berkefeld J, de Borst G, Bulbulia R, Halliday A . European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021; 6(2):I-XLVII. PMC: 8370069. DOI: 10.1177/23969873211012121. View

3.
Lescan M, Andic M, Bartos O, Schlensak C, Mustafi M . Carotid endarterectomy versus conservative management of the asymptomatic carotid stenosis before coronary artery bypass grafting: a retrospective study. BMC Cardiovasc Disord. 2020; 20(1):303. PMC: 7304183. DOI: 10.1186/s12872-020-01585-z. View

4.
Oka F, Ishihara H, Kato S, Oku T, Yamane A, Kunitugu I . Cerebral hemodynamic benefits after carotid artery stenting in patients with near occlusion. J Vasc Surg. 2013; 58(6):1512-7. DOI: 10.1016/j.jvs.2013.05.103. View

5.
Gorgulu S, Sahin M, Norgaz N, Pala S, Sari M, Yalcin A . Carotid artery stenting without embolic protection: A randomized multicenter trial (the CASWEP trial). Interv Neuroradiol. 2022; 29(4):419-425. PMC: 10399495. DOI: 10.1177/15910199221094388. View